The organizations of specialized medical care for patients with headache

Cover Page

Cite item

Full Text

Abstract

Primary headaches are common diseases in the clinical practice. Affecting the active, able-bodied population, impairing the quality of life and causing social maladjustment, they are of immense social significance. The medical care for patients with headaches ought to be complex and include a patient’s educational program, rational pharmaceutical therapy, detection and correction of comorbid functional disorders, nonpharmaceutical therapy. Despite an adequate therapy, the treatment satisfaction remains low and stimulates development of individualized treatment algorithms, that take into account the patient’s personal characteristics. They should be applicable both for the self treatment and for the use in the neurological and general practice.

About the authors

Liudmila I. Baiushkina

I.M. Sechenov First Moscow State Medical University (Sechenov University); Alexander Vein Headache Clinic

Author for correspondence.
Email: BaiushkinaLI@mail.ru
ORCID iD: 0000-0003-3741-5528
SPIN-code: 4571-3010

cоискатель канд. мед. наук; врач-невролог 

Russian Federation, Мoscow

References

  1. Rohling S, Funk A, Ruscheweyh R, et al. Integrated headache care at the outpatient headache center of the University Hospital of Munich: the Munich model. Clinical & Translational Neuroscience. July-Dec, 2018. Рр. 1-7. doi: 10.1177/2514183X18786844 journals.sagepub.com/home/ctn.
  2. Headache Classification Committee of the Inter-national Headache Society (IHS). Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi: 10.1177/0333102413485658.
  3. Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results study. Headache. 2012;52(10):1456-1470. doi: 10.1111/j.1526-4610.2012.02223.x.
  4. Ayzenberg I, Katsarava Z, Sborowski A, et al. The prevalence of primary headache disorders in Russia: a country wide survey. Cephalalgia. 2012; 32(5):373-381. doi: 10.1177/0333102412438977.
  5. Dodick DW, Turkel CC, DeGryse RE, et al. Onabotulinum toxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebocontrolled phases of the PREEMPT clinical program. Headache. 2010;50(6):921-936. doi: 10.1111/j.1526-4610.2010.01678.x.
  6. Наприенко М.В., Смекалкина Л.В., Сурнова Е.А. Эффективность разных доз препарата ботокс при лечении хронической мигрени // Журнал неврологии и психиатрии им. C.C. Корсакова. — 2017. — Т.117. — №8. — С. 44-48. [Naprienko MV, Smekalkina LV, Surnova EA. Efficacy of different doses of botox in treatment of chronic migraine. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(8):44-48. (In Russ).] doi: 10.17116/jnevro20171178144-48.
  7. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349. doi: 10.1212/01.wnl.0000252808.97649.21.
  8. Наприенко М.В., Смекалкина Л.В., Сафонов М.И., и др. Бремя мигрени в реальной клинической практике: клинические и экономические аспекты // Журнал неврологии и психиатрии им. C.C. Корсакова. — 2019. — Т.119. — №1. — С. 31-37. [Naprienko MV, Smekalkina LV, Safonov MI, et al. Real-world migraine burden: clinical and economic aspects. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(1):31-37. (In Russ).] doi: 10.17116/jnevro201911901131.
  9. Екушева Е.В., Дамулин И.В. Современные подходы к терапии рефрактерной мигрени // Российский медицинский журнал. — 2014. — Т.20. — №5. — С. 45-52. [Ekusheva EV, Damulin IV. The actual approaches to therapy of refractory migraine. Russian medical journal. 2014;20(5):45-52. (In Russ).]
  10. Екушева Е.В. Оптимальные подходы к купированию приступа мигрени: прошлое, настоящее и будущее // Российский медицинский журнал. — 2012. — Т.20. — №10. — С. 522-526. [Ekusheva EV. Optimal'nye podkhody k kupirovaniyu pristupa migreni: proshloe, nastoyashchee i budushchee. Russian medical journal. 2012;20(10):522-526. (In Russ).]
  11. Глембоцкая Г.Т., Козуб О.В. Фармакоэкономическая оценка бремени мигрени в Российской Федерации // Клиническая фармакология и терапия. — 2013. — Т.22. — №2. — С. 83-86. [Glembotskaya GT, Kozub OV. Farmakoekonomicheskaya otsenka bremeni migreni v Rossijskoj Federatsii. Klinicheskaya farmakologiya i terapiya. 2013;22(2):83-86. (In Russ).]
  12. D'Amico D, Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4(6):1155-1167. doi: 10.2147/ndt.s3497.
  13. Minen MT, Begasse De Dhaem O, Kroon Van Diest A, et al. Migraine and its psychiatric comorbidities. J Neurol Neurosurg Psychiatry. 2016;87(7):741-749. doi: 10.1136/jnnp-2015-312233.
  14. Lampl C, Thomas H, Tassorelli C, et al. Headache, depression and anxiety: associations in the Eurolight project. J Headache Pain. 2016;17:59. doi: 10.1186/s10194-016-0649-2.
  15. Breslau N, Schultz L, Stewart W, et al. Headache and major depression: Is the association specific to migraine? Neurology. 2000;54(2):308-313. doi: 10.1212/wnl.54.2.308.
  16. Buse DC, Silberstein SD, Manack AN, et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960-1969. doi: 10.1007/s00415-012-6725-x.
  17. Giannini G, Cevoli S, Sambati L, Cortelli P. Migraine: risk factor and comorbidity. Neurol Sci. 2012;33 Suppl 1:S37-41. doi: 10.1007/s10072-012-1029-6.
  18. Stewart WF, Wood GC, Manack A, et al. Employment and work impact of chronic migraine and episodic migraine. J Occup Environ Med. 2010;52(1):8-14. doi: 10.1097/JOM.0b013e3181c1dc56.
  19. Negro A, D’Alonzo L, Martelletti P. Chronic migraine: comorbidities, risk factors, and rehabilitation. Intern Emerg Med. 2010;5 Suppl 1:S13-9. doi: 10.1007/s11739-010-0457-7.
  20. Juang KD, Wang SJ, Fuh JL, et al. Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache. 2000;40(10):818-823. doi: 10.1046/j.1526-4610.2000.00148.x.
  21. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18 Suppl 22:56-58; discussion 58-61.
  22. Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag health study. Eur J Neurol. 2003;10(2): 147-152.
  23. Buse DC, Silberstein SD, Manack AN, et al. Psychiatric comorbidities of episodic and chronic migraine. J Neurol. 2013;260(8):1960-1969. doi: 10.1007/s00415-012-6725-x.
  24. Baskin SM, Lipchik GL, Smitherman TA. Mood and anxiety disorders in chronic headache. Headache. 2006;46 Suppl 3:S76-S87. doi: 10.1111/j.1526-4610.2006.00559.x
  25. Felbinger J, Reinisch V, Sostak P, et al. Angst und depression bei Kopfschmerzpatienten. Der Schmerz. 2009; 23(1): 33-39. doi: org/10.1007/s00482-008-0735-8.
  26. Blumenfeld A, Varon S, Wilcox T, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-315. doi: 10.1177/0333102410381145.
  27. Peterlin BL, Rosso AL, Sheftell FD, et al. Post-traumatic stress disorder, drug abuse and migraine: new findings from the National Comorbidity Survey Replication (NCS-R). Cephalalgia. 2011;31(2):235-244. doi: 10.1177/0333102410378051.
  28. Peterlin BL, Tietjen GE, Brandes JL, et al. Posttraumatic stress disorder in migraine. Headache. 2009;49(4):541-551. doi: 10.1111/j.1526-4610.2009.01368.x.
  29. Гамбург А.Л., Лившиц Л.Я., Кром В.А., Ямпольский Л.Б. Психофармакология психических нарушений у больных с хронической болью // Неврологический вестник. — 1994. — Т.XXVI. — №3-4. — С. 28-31. [Gamburg AL, Livshits LYa, Krom VA, Yampol'skij LB. Psikhofarmakologiya psikhicheskikh narushenij u bol'nykh s khronicheskoj bol'yu. Nevrologicheskij vestnik. 1994;XXVI(3-4):28-31. (In Russ).]
  30. Gaul C, Liesering-Latta E, Schäfer B, et al. Integrated multidisciplinary care of headache disorders: a narrative review. Cephalalgia. 2016;36(12):1181-1191. doi: 10.1177/0333102415617413.
  31. Wallasch T-M, Straube A, Storch P, et al. Die integrierte Versorgung Kopfschmerz. Nervenheilkunde. 2009;28(6):361-364.
  32. Kaiser U, Sabatowski R and Azad S. [Multimodal pain therapy. Current situation. (Article in German).]. Schmerz. 2015;29(5):550-556. doi: 10.1007/s00482-015-0030-4.
  33. Nicholson RA, Buse DC, Andrasik F, Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol. 2011;13(1):28-40. doi: 10.1007/s11940-010-0102-9.
  34. Fritsche G, Kröner-Herwig B, Kropp P, et al. Psychologische therapie der migräne. Der Schmerz. 2013;27(3):263-274. doi: 10.1007/s00482-013-1319-9.
  35. Blau J, MacGregor E. Migraine and the neck. Headache. 1994;34(2):88-90.
  36. Florencio LL, Chaves TC, Carvalho GF, et al. Neck pain disability is related to the frequency of migraine attacks: a cross-sectional study. Headache. 2014;54(7):1203-1210. doi: 10.1111/head.12393.
  37. Наприенко М.В., Смекалкина Л.В. Стратегии повышения эффективности терапии хронической мигрени // Журнал неврологии и психиатрии им. С.С. Корсакова. — 2015. — Т.115. — №12. — С. 70-73. [Naprienko MV, Smekalkina LV. Strategies on the improvement of chronic migraine treatment efficacy. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015;115(12):70-73. (In Russ).] doi: 10.17116/jnevro201511511270-73.
  38. Ефремова И.Н., Баюшкина Л.И., Наприенко М.В., и др. Программа для обучения релаксации при хронической мигрени. Государственная регистрация программы для ЭВМ № 2019614503. 05.04.2019. Бюл. №4. [Efremova IN, Bayushkina LI, Naprienko MV, i dr. Programma dlya obucheniya relaksatsii pri khronicheskoj migreni. Gosudarstvennaya registratsiya programmy dlya EVM № 2019614503. 05.04.2019. Byul. №4. (In Russ).] Доступно по: https://www1.fips.ru/wps/PA_FipsPub/res/Doc/PrEVM/RUNWPR/000/002/019/614/503/2019614503-00001/DOCUMENT.PDF. Ссылка активна на 13.04.2019.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. The structure of primary headaches in the Clinic of headache and autonomic disorders named. Academician Alexander Wayne in 2018

Download (98KB)
Indexing metadata
3. Fig. 2. The reasons for seeking help at the Clinic of headache and autonomic disorders named after Academician Alexander Wayne

Download (75KB)
Indexing metadata
4. Fig. 3. Patient satisfaction with various treatment regimens at the Clinic of Headache and Autonomic Disorders named after Academician Alexander Wayne

Download (93KB)
Indexing metadata

Copyright (c) 2019 Baiushkina L.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies